Radnor Capital Management LLC raised its holdings in Brookfield Co. (NYSE:BN – Free Report) by 4.3% in the third quarter, according to the company in its most recent disclosure with the SEC. The fund owned 36,783 shares of the company’s stock after buying an additional 1,518 shares during the quarter. Radnor Capital Management LLC’s holdings in Brookfield were worth $1,955,000 at the end of the most recent reporting period.
Other institutional investors have also recently modified their holdings of the company. Blue Trust Inc. raised its stake in shares of Brookfield by 62.8% in the second quarter. Blue Trust Inc. now owns 705 shares of the company’s stock worth $30,000 after purchasing an additional 272 shares during the last quarter. Kings Path Partners LLC acquired a new stake in shares of Brookfield in the second quarter worth approximately $31,000. Family Firm Inc. purchased a new position in Brookfield during the second quarter worth approximately $36,000. Nisa Investment Advisors LLC lifted its position in Brookfield by 63.5% during the second quarter. Nisa Investment Advisors LLC now owns 1,159 shares of the company’s stock worth $48,000 after buying an additional 450 shares in the last quarter. Finally, Asset Dedication LLC purchased a new position in Brookfield during the second quarter worth approximately $56,000. 61.60% of the stock is currently owned by hedge funds and other institutional investors.
Brookfield Price Performance
BN stock opened at $55.75 on Wednesday. Brookfield Co. has a 1 year low of $31.43 and a 1 year high of $56.83. The company has a debt-to-equity ratio of 1.39, a quick ratio of 1.03 and a current ratio of 1.20. The stock’s 50 day moving average price is $51.91 and its 200 day moving average price is $46.67. The firm has a market cap of $91.78 billion, a P/E ratio of 96.12 and a beta of 1.53.
Brookfield Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Friday, September 27th. Stockholders of record on Thursday, September 12th were given a dividend of $0.08 per share. The ex-dividend date of this dividend was Thursday, September 12th. This represents a $0.32 annualized dividend and a dividend yield of 0.57%. Brookfield’s payout ratio is 55.17%.
Analysts Set New Price Targets
A number of research firms have commented on BN. Royal Bank of Canada reduced their target price on Brookfield from $57.00 to $56.00 and set an “outperform” rating on the stock in a research report on Friday, August 9th. BMO Capital Markets boosted their price objective on Brookfield from $48.00 to $50.00 and gave the company an “outperform” rating in a report on Wednesday, September 11th. Scotiabank lifted their target price on Brookfield from $51.25 to $65.00 and gave the company an “outperform” rating in a research report on Wednesday, October 30th. TD Securities lifted their target price on Brookfield from $62.00 to $63.00 and gave the company a “buy” rating in a report on Monday, August 12th. Finally, JPMorgan Chase & Co. lifted their target price on Brookfield from $49.00 to $52.00 and gave the company an “overweight” rating in a report on Wednesday, July 31st. Two analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to data from MarketBeat.com, Brookfield currently has a consensus rating of “Moderate Buy” and a consensus target price of $53.31.
View Our Latest Report on Brookfield
Brookfield Company Profile
Brookfield Corporation is an alternative asset manager and REIT/Real Estate Investment Manager firm focuses on real estate, renewable power, infrastructure and venture capital and private equity assets. It manages a range of public and private investment products and services for institutional and retail clients.
Read More
- Five stocks we like better than Brookfield
- How to Use Stock Screeners to Find Stocks
- 2 Alternative Internet Stocks Staging a Breakout in 2024
- Retail Stocks Investing, Explained
- Discover the 3 Best-Performing Biotech IPO Stocks of 2024
- Trading Stocks: RSI and Why it’s Useful
- Hims & Hers: Why This Healthcare Stock’s Growth Makes It a Buy
Receive News & Ratings for Brookfield Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Brookfield and related companies with MarketBeat.com's FREE daily email newsletter.